06.03.2021 18:50:49
|
Moderna To Supply 13 Mln Doses Of COVID-19 Vaccine To The Philippines
(RTTNews) - Moderna, Inc. (MRNA) announced that it has supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna.
As per the terms of deal, deliveries would begin in mid-2021.
The COVID-19 Vaccine Moderna is not currently approved for use in the Philippines. But the Company will work with regulators to pursue necessary approvals prior to distribution, the company said in a statement.
The company also stated that the separate agreement with the Philippine Government and private sector for the supply of an additional 7 million doses is also anticipated.
"We thank the Government and the private sector for their collaboration to bring the COVID-19 Vaccine Moderna to the Philippines," said Stphane Bancel, Chief Executive Officer of Moderna.
"We appreciate the confidence in Moderna, and our mRNA platform demonstrated by the Government of the Philippines. We remain committed to making our vaccine available on every continent to help end this global pandemic."
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Moderna Incmehr Nachrichten
20:04 |
Minuszeichen in New York: NASDAQ 100 zeigt sich am Montagnachmittag leichter (finanzen.at) | |
18:02 |
Gewinne in New York: Anleger lassen S&P 500 am Mittag steigen (finanzen.at) | |
18:02 |
Börse New York in Grün: NASDAQ 100 am Mittag fester (finanzen.at) | |
16:03 |
Aufschläge in New York: S&P 500 klettert zum Start (finanzen.at) | |
16:03 |
Börse New York: NASDAQ 100 notiert zum Start im Plus (finanzen.at) | |
22.11.24 |
Optimismus in New York: S&P 500 beendet die Sitzung weit in der Gewinnzone (finanzen.at) | |
22.11.24 |
NASDAQ-Handel: NASDAQ 100 letztendlich mit Kursplus (finanzen.at) | |
22.11.24 |
Handel in New York: NASDAQ 100-Börsianer greifen am Nachmittag zu (finanzen.at) |
Analysen zu Moderna Incmehr Analysen
19.11.24 | Moderna Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.09.24 | Moderna Underweight | JP Morgan Chase & Co. | |
05.08.24 | Moderna Sector Perform | RBC Capital Markets | |
12.01.24 | Moderna Outperform | RBC Capital Markets | |
03.11.23 | Moderna Buy | Goldman Sachs Group Inc. |